Javascript must be enabled to continue!
A serpin‐induced extensive proteolytic susceptibility of urokinase‐type plasminogen activator implicates distortion of the proteinase substrate‐binding pocket and oxyanion hole in the serpin inhibitory mechanism
View through CrossRef
The formation of stable complexes between serpins and their target serine proteinases indicates formation of an ester bond between the proteinase active‐site serine and the serpin P1 residue [Egelund, R., Rodenburg, K.W., Andreasen, P.A., Rasmussen, M.S., Guldberg, R.E. & Petersen, T.E. (1998) Biochemistry37, 6375–6379]. An important question concerning serpin inhibition is the contrast between the stability of the ester bond in the complex and the rapid hydrolysis of the acyl‐enzyme intermediate in general serine proteinase‐catalysed peptide bond hydrolysis. To answer this question, we used limited proteolysis to detect conformational differences between free urokinase‐type plasminogen activator (uPA) and uPA in complex with plasminogen activator inhibitor‐1 (PAI‐1). Whereas the catalytic domain of free uPA, pro‐uPA, uPA in complex with non‐serpin inhibitors and anhydro‐uPA in a non‐covalent complex with PAI‐1 was resistant to proteolysis, the catalytic domain of PAI‐1‐complexed uPA was susceptible to proteolysis. The cleavage sites for four different proteinases were localized in specific areas of the C‐terminal β‐barrel of the catalytic domain of uPA, providing evidence that the serpin inhibitory mechanism involves a serpin‐induced massive rearrangement of the proteinase active site, including the specificity pocket, the oxyanion hole, and main‐chain binding area, rendering the proteinase unable to complete the normal hydrolysis of the acyl‐enzyme intermediate. The distorted region includes the so‐called activation domain, also known to change conformation on zymogen activation.
Title: A serpin‐induced extensive proteolytic susceptibility of urokinase‐type plasminogen activator implicates distortion of the proteinase substrate‐binding pocket and oxyanion hole in the serpin inhibitory mechanism
Description:
The formation of stable complexes between serpins and their target serine proteinases indicates formation of an ester bond between the proteinase active‐site serine and the serpin P1 residue [Egelund, R.
, Rodenburg, K.
W.
, Andreasen, P.
A.
, Rasmussen, M.
S.
, Guldberg, R.
E.
& Petersen, T.
E.
(1998) Biochemistry37, 6375–6379].
An important question concerning serpin inhibition is the contrast between the stability of the ester bond in the complex and the rapid hydrolysis of the acyl‐enzyme intermediate in general serine proteinase‐catalysed peptide bond hydrolysis.
To answer this question, we used limited proteolysis to detect conformational differences between free urokinase‐type plasminogen activator (uPA) and uPA in complex with plasminogen activator inhibitor‐1 (PAI‐1).
Whereas the catalytic domain of free uPA, pro‐uPA, uPA in complex with non‐serpin inhibitors and anhydro‐uPA in a non‐covalent complex with PAI‐1 was resistant to proteolysis, the catalytic domain of PAI‐1‐complexed uPA was susceptible to proteolysis.
The cleavage sites for four different proteinases were localized in specific areas of the C‐terminal β‐barrel of the catalytic domain of uPA, providing evidence that the serpin inhibitory mechanism involves a serpin‐induced massive rearrangement of the proteinase active site, including the specificity pocket, the oxyanion hole, and main‐chain binding area, rendering the proteinase unable to complete the normal hydrolysis of the acyl‐enzyme intermediate.
The distorted region includes the so‐called activation domain, also known to change conformation on zymogen activation.
Related Results
Binding of human plasminogen to Borrelia burgdorferi
Binding of human plasminogen to Borrelia burgdorferi
We studied the binding of plasminogen to Borrelia burgdorferi, a spirochete which causes Lyme disease and produces no endogenous proteases which digest extracellular matrix protein...
Randomized, double-blinded multicenter study. Comparison of intracoronary single-chain urokinase-type plasminogen activator, pro-urokinase (GE-0943), and intracoronary urokinase in patients with acute myocardial infarction.
Randomized, double-blinded multicenter study. Comparison of intracoronary single-chain urokinase-type plasminogen activator, pro-urokinase (GE-0943), and intracoronary urokinase in patients with acute myocardial infarction.
Coronary recanalization rates and changes in the coagulation and fibrinolysis system were evaluated in a randomized fashion in patients with acute myocardial infarction after intra...
Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro.
Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro.
Urokinase is a neutral protease whose major site of action is the external surface of the plasma membrane of cells and whose major function seems to be modulation of cell adhesion,...
Physiology of Plasminogen: With Special Reference to Activation and Degradation
Physiology of Plasminogen: With Special Reference to Activation and Degradation
Plasminogen is said to be synthesized in many organs, but the major source of its production is considered to be the liver. The production of plasminogen is observed in fetal life,...
Computational characterization of the interactions between novel Boronic Acid derivatives with urokinase-type plasminogen activator (uPA) and their binding energy
Computational characterization of the interactions between novel Boronic Acid derivatives with urokinase-type plasminogen activator (uPA) and their binding energy
1.
Abstract
Urokinase type plasminogen activator is expected to play a significant role in metastasis therefore various inhibitor...
Plasminogen interactions with platelets in plasma
Plasminogen interactions with platelets in plasma
In this report we used a fluorescent flow cytometry-based assay to examine plasminogen binding to platelets in plasma. Our data indicate that platelets activated in platelet-rich p...
Plasminogen interactions with platelets in plasma
Plasminogen interactions with platelets in plasma
Abstract
In this report we used a fluorescent flow cytometry-based assay to examine plasminogen binding to platelets in plasma. Our data indicate that platelets acti...

